Development and application of simple HPLC-UV method for fluconazole quantification in human plasma

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL. 4, 2012, Pages 107-111

  Liew, Kai Bin ^a   Loh, Gabriel Onn Kit ^a   Tan, Yvonne Tze Fung ^a   Peh, Kok Khiang ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; FLUCONAZOLE; TINIDAZOLE;

ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID LIQUID EXTRACTION; NORMAL HUMAN; PH; ULTRAVIOLET RADIATION;

EID: 84866319420     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Eerkes A., Shou W.Z., Weng N.D. Liquid-liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the analysis of fluconazole in human plasma. J Pharmaceut Biomed. 2003; 31: 917-928.
2. Porta V., Chang K.H., Storpirtis S. Evaluation of the bioequivalence of capsules containing 150mg of fluconazole. Int J Pharmaceut. 2005; 288: 81-86.
3. Joseph T.D., Robert L.T., Gary C.Y., Gary R.M., Barbara G.W., Michael P. Eds. Pharmacotherapy: A Pathophysiologic Approach. Sixth Ed. London: Mc. Graw Hill.; 2005.
4. Lacy C.F., Armstrong L.L., Goldman M.P., Lance L.L. Eds. Drug Information Handbook, Fifteen Ed. Ohio: LEXI-COMP, 2006.
5. Wood P.R., Tarbit M.H. Gas chromatographic method for the determination of fluconazole, a novel antifungal agent, in human plasma and urine. J Chromatogr. 1986; 383: 179-186.
6. Heeren F.V., Tanner R., Theurillat R., Thormann W. Determination of fluconazole in human plasma by micellar electrokinetic capillary chromatography with detection at 190nm. J Chromatogr A. 1996; 745: 165-172.
7. Majcherczyk P.A., Moreillon P., Decosterd L.A., Sanglard D., Bille J., Glauser M.P., Marchetti O. Single-step extraction of fluconazole from by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography. J Pharmaceut Biomed. 2002; 28: 645-651.
8. Mathy F.X., Vroman B., Ntivunwa D., Winne A.D., Verbeeck R.K., Preat V. On-line determination of fluconazole in blood and dermal rat microdialysates by microbore high-performance liquid chromatography. J Chromatogr B. 2003; 787: 323-331.
9. Sun S.J., Lou H.X., Gao Y.H., Fan P.H., Ma B., Ge W.Y., Wang X.N. Liquid chromatography-tandem mass spectrometric method for the analysis of fluconazole and evaluation of the impact of phenolic compounds on the concentration of fluconazole in Candida albicans. J Pharmaceut biomed. 2004; 34: 1117-1124.
10. Moura E.A., Correia L.P., Pinto M.F., Procopio J.V.V., Souza F.S., MacEdo R.O. Thermal characterization of the solid state and raw material fluconazole by thermal analysis and pyrolisis coupled to GC/MS. J Therm Anal Calorim. 2010; 100: 289-293.
11. Dongre V.G., Karmusea P.P., Ghugre P.D., Salunke S.M., Panda N., Kumarb A. Preparative isolation and structural elucidation of impurities in fluconazole by LC/MS/MS. J Pharmaceut Biomed. 2006; 42: 334-340.
12. Kim S.S., Ho T.I., Kang I.M., Lee H.S., Lee H.W., Cho S.H., Kim J.B., Lee K.T. An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study. J Chromatogr B. 2007; 852: 174-179.
13. Davies I.D., Allanson J.P., Causon R.C. Rapid determination of the anti-cancer drug chlorambucil (Leukeran™) and its phenyl acetic acid mustard metabolite in human serum and plasma by automated solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr B. 1999; 732: 173-184.
14. Brijesh S., Patel D.K., Ghosh S.K. A Reversed-phase high performance liquid chromatographic method for determination of chlorthalidone in pharmaceutical formulation. IJPPS. 2009; 1(2): 24-29.
15. Lakshmi K.S., Rajesh T., Shrinivas S. Simultaneous determination of metformin and pioglitazone by reversed phase HPLC in pharmaceutical dosage forms. IJPPS. 2009; 1(2): 162-166.